At the time of writing, Cardlytics Inc [CDLX] stock is trading at $2.47, up 19.32%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The CDLX shares have gain 23.50% over the last week, with a monthly amount drifted -27.99%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Cardlytics Inc [NASDAQ: CDLX] stock has seen the most recent analyst activity on October 11, 2024, when Evercore ISI initiated its In-line rating and assigned the stock a price target of $4. Previously, Northland Capital downgraded its rating to Market Perform on August 16, 2024, and kept the price target unchanged to $5. On August 15, 2024, downgrade downgraded it’s rating to Underperform and revised its price target to $3.50 on the stock. Needham downgraded its rating to a Hold. Lake Street downgraded its rating to a Hold and reduced its price target to $5 on August 08, 2024. Craig Hallum downgraded its rating to Hold for this stock on August 08, 2024.
For the past year, the stock price of Cardlytics Inc fluctuated between $1.77 and $20.52. Currently, Wall Street analysts expect the stock to reach $4 within the next 12 months. Cardlytics Inc [NASDAQ: CDLX] shares were valued at $2.47 at the most recent close of the market. An investor can expect a potential return of 61.94% based on the average CDLX price forecast.
Analyzing the CDLX fundamentals
According to Cardlytics Inc [NASDAQ:CDLX], the company’s sales were 293.47M for trailing twelve months, which represents an -15.12% plunge. Gross Profit Margin for this corporation currently stands at 0.59% with Operating Profit Margin at -0.53%, Pretax Profit Margin comes in at -0.68%, and Net Profit Margin reading is -0.68%. To continue investigating profitability, this company’s Return on Assets is posted at -0.48, Equity is -1.38 and Total Capital is -0.61. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of3.17.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 2.25 points at the first support level, and at 2.04 for the second support level. However, for the 1st resistance point, the stock is sitting at 2.59, and for the 2nd resistance point, it is at 2.72.
Ratios To Look Out For
It is important to note that Cardlytics Inc [NASDAQ:CDLX] has a current ratio of 1.18. Further, the Quick Ratio stands at 1.18, while the Cash Ratio is 0.44. Considering the valuation of this stock, the price to sales ratio is 0.44, the price to book ratio is 1.78.
Transactions by insiders
Recent insider trading involved Gupta Amit, Chief Executive Officer, that happened on Feb 19 ’25 when 54565.0 shares were sold. Chief Executive Officer, Gupta Amit completed a deal on Feb 18 ’25 to sell 46857.0 shares. Meanwhile, Officer Gupta Amit bought 54565.0 shares on Feb 19 ’25.
